ASP7147

ASP7147 · Seldar Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP7147, covering 2019-06-06 to 2019-06-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]

See pricing